• 1. Investigation of arene–arene interaction in stereoselective MCPBA epoxidation
  Keiki Kishikawa,Mamoru Naruse,Shigeo Kohmoto,Makoto Yamamoto,Kentaro Yamaguchi J. Chem. Soc. Perkin Trans. 1 2001 462

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolines Phenylpyrrolines

Introduction to 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione (CAS No. 4338-06-1)

1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione is a significant compound in the field of pharmaceutical chemistry and medicinal biology, characterized by its unique structural and functional properties. This heterocyclic compound belongs to the pyrrole dione class, which has garnered considerable attention due to its versatile applications in drug discovery and synthetic chemistry. The presence of both a nitro group and a pyrrole ring system imparts distinct reactivity and biological potential, making it a valuable scaffold for developing novel therapeutic agents.

The chemical structure of 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione consists of a pyrrole ring fused with a dione moiety, further substituted with a 4-nitrophenyl group at the C1 position. This arrangement contributes to its stability and reactivity under various chemical conditions, enabling diverse synthetic pathways for derivatization. The nitro group not only enhances the compound's electrophilicity but also influences its electronic properties, making it a promising candidate for interactions with biological targets.

In recent years, there has been growing interest in exploring the pharmacological properties of pyrrole derivatives, particularly those incorporating dione functionalities. These compounds have shown promise in various preclinical studies as potential inhibitors of key enzymes and receptors involved in inflammatory diseases, cancer, and neurodegenerative disorders. The 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione structure has been investigated for its ability to modulate biological pathways by acting as a competitive antagonist or substrate mimic.

One of the most compelling aspects of this compound is its potential as a kinase inhibitor. Kinases are enzymes that play critical roles in cell signaling pathways, and their dysregulation is often associated with pathological conditions. Studies have demonstrated that pyrrole-based inhibitors can effectively target specific kinases by binding to their active sites. The nitro group in 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione enhances its interaction with the heme groups of certain enzymes, improving binding affinity and efficacy.

Furthermore, the dione moiety contributes to the compound's ability to undergo redox reactions, which is particularly relevant in therapeutic contexts where oxidative stress plays a role in disease progression. This property makes 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione a candidate for developing antioxidants or prodrugs that can release active species under pathological conditions.

Recent advancements in computational chemistry have enabled more efficient screening of potential drug candidates. Molecular docking studies have been performed using 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione as a lead compound to identify optimal binding interactions with target proteins. These studies have revealed promising binding affinities with enzymes such as COX-2 and certain tyrosine kinases, suggesting its utility in treating inflammation and cancer.

The synthesis of 1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione involves multi-step organic reactions that highlight the compound's synthetic versatility. The introduction of the nitro group at the phenyl ring can be achieved through nitration or metal-catalyzed coupling reactions. Subsequent functionalization of the pyrrole ring through cyclization or condensation reactions allows for further diversification of the scaffold. These synthetic strategies have been optimized to ensure high yields and purity, making the compound accessible for downstream applications.

In conclusion,1-(4-Nitrophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione (CAS No. 4338-06-1) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features enable diverse biological activities and synthetic modifications, positioning it as a valuable tool for drug discovery efforts aimed at addressing various diseases. As research continues to uncover new therapeutic applications for pyrrole derivatives,this compound is likely to remain at the forefront of medicinal chemistry innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)